Valeant Pharmaceuticals International Inc. received a joint takeover approach this spring from Japan’s Takeda Pharmaceutical Co. and private-equity firm TPG that the beleaguered drug maker rejected, according to people familiar with the matter.
MarketWatch.com - Top Stories, MarketWatch
Thu, 05/26/2016 - 4:43pm
Valeant Pharmaceuticals International Inc. received a joint takeover approach this spring from Japan’s Takeda Pharmaceutical Co. and private-equity firm TPG that the beleaguered drug maker rejected, according to people familiar with the matter.